Second Quarter 2022 Performance - Net sales reached $115 million, a 13% increase compared to the prior year[8] - Adjusted EBITDA was $7 million, representing a 6% margin[8] - The Vita Coco brand achieved a 51% market share in IRI tracked channels as of the 52 weeks ending June 26, 2022[8] - Vita Coco Coconut Water net sales grew by 21%[8] Financial Highlights - Q2 2022 gross profit was $29 million, with a 25% margin, a decrease of 3 percentage points[17] - Q2 2022 net income was $1 million, representing a 1% margin[25] - Case Equivalent (CE) volumes increased by 7%[8] Brand Performance and Growth - Vita Coco's market share in the US grew by 7% to reach 51%[10, 11] - Household penetration increased by 17%[14] - Shoppers are buying Vita Coco products 7% more often[15] - Spend per trip increased by 6% to $764[16] 2022 Full Year Guidance - The company reaffirmed its net sales guidance of $440-455 million, representing a 16-20% growth[23] - Adjusted EBITDA is projected to be $27-32 million[23]

©2022 THE VITA COCO COMPANY. PROPRIETARY AND CONFIDENTIAL 1 COMPANY THE PIONEER IN THE NATURAL & PLANT-BASED REVOLUTION 1 ST QUARTER 2022 RESULTS DISCLAIMER Non-GAAP Financial Measures In addition to disclosing results determined in accordance with U.S. GAAP, The Vita Coco Company, Inc. (the "Company") also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, that include certain adjustments or exclude certain charges and gains that are described in the reconcili ...

Table of Contents ____________________ ____________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 Per Share COCO The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ____________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ...

The Vita Coco Company, Inc. (NASDAQ:COCO) Q1 2022 Results Conference Call May 11, 2022 5:00 PM ET Company Participants John Mills - Investor Relations, ICR Michael Kirban - Chairman, Co-Founder Martin Roper - Chief Executive Officer Kevin Benmoussa - Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Laurent Grandet - Guggenheim Brian Stein - Bank of America Chris Carey - Wells Fargo Robert Ottenstein - Evercore ISI David Shakno - William Blair Operator Hello and welcome to t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40950 The Vita Coco Company Inc. (Exact name of Registrant as specified in its Charter) Delaware 11-3713156 (State ...

The Vita Coco Company, Inc. (NASDAQ:COCO) Q4 2021 Earnings Conference Call March 10, 2022 8:30 AM ET Company Participants John Mills - Investor Relations, ICR Mike Kirban - Chairman, Co-Founder, Co-Chief Executive Officer Martin Roper - Co-Chief Executive Officer Kevin Benmoussa - Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Laurent Grandet - Guggenheim Kaumil Gajrawala - Credit Suisse Chris Carey - Wells Fargo Securities Michael Lavery - Piper Sandler Jon Andersen - Wi ...

©2022 THE VITA COCO COMPANY. PROPRIETARY AND CONFIDENTIAL 1 COMPANY THE PIONEER IN THE NATURAL & PLANT-BASED REVOLUTION 4 TH QUARTER & FULL YEAR 2021 RESULTS DISCLAIMER Non-GAAP Financial Measures In addition to disclosing results determined in accordance with U.S. GAAP, The Vita Coco Company, Inc. (the "Company") also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, that include certain adjustments or exclude certain charges and gains that are described in t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40950 The Vita Coco Company, Inc. (Exact Name of Registrant as Specified in its Charter) | --- | |--------- ...